Important safety information
Indication
SANCUSO® (Granisetron Transdermal System) is indicated for the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy regimens of up to 5 consecutive days duration1
Contraindication
- SANCUSO is contraindicated in patients with known hypersensitivity to granisetron or to any of the components of the patch1
Application site reactions
- Mild application site reactions have occurred; remove the patch if severe reaction or a generalized skin reaction occurs1
Sun exposure
- Patients should avoid direct exposure of application site to natural or artificial sunlight by covering with clothing while wearing the patch and for 10 days after removing it1
Adverse reactions
- The most common adverse reaction in patients receiving SANCUSO is constipation (5.4%)1